Invention Grant
- Patent Title: KLK4 inhibitors
-
Application No.: US15128446Application Date: 2015-03-30
-
Publication No.: US10017527B2Publication Date: 2018-07-10
- Inventor: Jurgen Joossens , Koen Augustyns , Anne-Marie Lambeir , Pieter Van Der Veken , Jeroen Van Soom , Viktor Magdolen
- Applicant: Universiteit Antwerpen
- Applicant Address: BE Antwerp
- Assignee: UNIVERSITEIT ANTWERPEN
- Current Assignee: UNIVERSITEIT ANTWERPEN
- Current Assignee Address: BE Antwerp
- Agency: Dinsmore & Shohl LLP
- Priority: EP14162227 20140328
- International Application: PCT/EP2015/056908 WO 20150330
- International Announcement: WO2015/144933 WO 20151001
- Main IPC: C07F9/6561
- IPC: C07F9/6561 ; C07F9/40 ; A61K49/00 ; C07F9/58 ; C07F9/655 ; C07F9/6553 ; C07F9/6509 ; C07F9/6558 ; C12Q1/37

Abstract:
The present invention relates to novel compounds and probes which have a common chemical structure necessary to obtain potent inhibitory activity against KLK4 and/or may be used for the detection of KLK4 peptides and their activity. It further relates to the use of these compounds and methods for inhibiting and/or detecting KLK4 activity in vitro and in vivo by making use of said probes or inhibitors. The compounds of the invention differ from prior art compounds at least in the presence of phenyl guanidine (instead of e.g. benzyl guanidine) and/or the presence of a heteroatom in the tail group, their combined presence unexpectedly leading to potent and selective KLK4 inhibitory activity.
Public/Granted literature
- US20170101427A1 NOVEL KLK4 INHIBITORS Public/Granted day:2017-04-13
Information query